Review article · 2014 · Open access

Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates

B.C. Doak, Björn Over, Fabrizio Giordanetto, Jan O. Kihlberg

Chemistry & Biology, 21(9), 1115–1142 · Published 1 September 2014 · DOI 10.1016/j.chembiol.2014.08.013

Free PDFView at the publisherCite this paper

In brief

“Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates” is a 2014 review article by B.C. Doak and 3 co-authors, published in Chemistry & Biology. OpenAlex counts 873 citations as of 15 November 2026. It is open access under a public domain licence: the full text is free to read at Chemistry & Biology.

Citations
873
Most cited in
2026 (124)
Field-weighted impact
2.23
References
295
Authors
4

Abstract

The rule of 5 (Ro5) is a set of in silico guidelines applied to drug discovery to prioritize compounds with an increased likelihood of high oral absorption. It has been influential in reducing attrition due to poor pharmacokinetics over the last 15 years. However, strict reliance on the Ro5 may have resulted in lost opportunities, particularly for difficult targets. To identify opportunities for oral drug discovery beyond the Ro5 (bRo5), we have comprehensively analyzed drugs and clinical candidates with molecular weight (MW) > 500 Da. We conclude that oral drugs are found far bRo5 and properties such as intramolecular hydrogen bonding, macrocyclization, dosage, and formulations can be used to improve bRo5 bioavailability. Natural products and structure-based design, often from peptidic leads, are key sources for oral bRo5 drugs. These insights should help guide the design of oral drugs in bRo5 space, which is of particular interest for difficult targets.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Doak, B., Over, B., Giordanetto, F., & Kihlberg, J. O. (2014). Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. Chemistry & Biology, 21(9), 1115–1142. https://doi.org/10.1016/j.chembiol.2014.08.013

MLA 9

Doak, B.C., et al. “Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates.” Chemistry & Biology, vol. 21, no. 9, 2014, pp. 1115–1142. https://doi.org/10.1016/j.chembiol.2014.08.013.

Chicago

Doak, B.C., Björn Over, Fabrizio Giordanetto, and Jan O. Kihlberg. 2014. “Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates.” Chemistry & Biology 21 (9): 1115–1142. https://doi.org/10.1016/j.chembiol.2014.08.013.

Harvard

Doak, B. et al. (2014) ‘Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates’, Chemistry & Biology, 21(9), pp. 1115–1142. doi:10.1016/j.chembiol.2014.08.013.

IEEE

B. Doak, B. Over, F. Giordanetto, and J. O. Kihlberg, “Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates,” Chemistry & Biology, vol. 21, no. 9, pp. 1115–1142, 2014, doi: 10.1016/j.chembiol.2014.08.013.

BibTeX

@article{doak2014oral,
  title     = {{Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates}},
  author    = {Doak, B.C. and Over, Björn and Giordanetto, Fabrizio and Kihlberg, Jan O.},
  journal   = {Chemistry \& Biology},
  year      = {2014},
  volume    = {21},
  number    = {9},
  pages     = {1115--1142},
  doi       = {10.1016/j.chembiol.2014.08.013},
  url       = {https://doi.org/10.1016/j.chembiol.2014.08.013}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
20172929
20185151
20195050
20206565
20218686
2022103103
2023113113
2024110110
20258888
2026124124

Its field-weighted citation impact is 2.23: it has been cited 2.23 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • Rule of 5
  • oral bioavailability
  • drug discovery
  • molecular weight
  • intramolecular hydrogen bonding
  • macrocyclization
  • oral dosage forms
  • natural products

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Doak, B., Over, B., Giordanetto, F., & Kihlberg, J. O. (2014). Oral Druggable Space beyond the Rule of 5: Insights from Drugs and Clinical Candidates. Chemistry & Biology, 21(9), 1115–1142. https://doi.org/10.1016/j.chembiol.2014.08.013

How many times has this paper been cited?

873 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Chemistry & Biology.

Who wrote this paper?

B.C. Doak, Björn Over, Fabrizio Giordanetto, Jan O. Kihlberg.

What is the DOI of this paper?

10.1016/j.chembiol.2014.08.013. The permanent link is https://doi.org/10.1016/j.chembiol.2014.08.013.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.